CIITA and neoplasm: From these results, we conclude that MOC2 tumor cells of aggressive behavior in vivo not only can be rejected or strongly delayed in their growth after de novo expression of CIITA-mediated MHC-II molecules, but also induce an immunological memory capable to confer resistance to challenge with MHC-II-negative parental tumors.